For OS, high DCAF7 expression was associated with poorer outcomes in adrenocortical carcinoma (ACC), LIHC, mesothelioma (MESO) and skin cutaneous melanoma (SKCM) (p < .05; HR > 1). This evidence concerns the gene DCAF7 and cutaneous melanoma.